Quantum-Si aims to revolutionize protein sequencing amidst technological hurdles, uncertain advancements, and market ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...

SI-BONE (NASDAQ:SIBN – Free Report) had its target price increased by Needham & Company ... The company reported ($0.11) earnings per share for the quarter, topping analysts’ consensus ...

Needham analyst David Saxon raised the firm’s price target on SI-Bone (SIBN) to $24 from $20 and keeps a Buy rating on the shares. The ...

Alliance Global Partners lowered the firm’s price target on Quantum-Si (QSI) to $3.65 from $3.75 and keeps a Buy rating on the shares following ...

Quantum-Si is a biotech star, with a 327% surge in stock price. Its proteomics platform and partnerships make it one to watch in 2025.

Stock analysts at HC Wainwright issued their FY2029 EPS estimates for shares of Quantum-Si in a note issued to investors on Tuesday, March 4th. HC Wainwright analyst S. Ramakanth expects that the ...